Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2020 Jul 10;17(8):894. doi: 10.1038/s41423-020-0498-4

Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion

Xinling Wang 1,#, Wei Xu 1,#, Gaowei Hu 1,#, Shuai Xia 1, Zhiping Sun 1, Zezhong Liu 1, Youhua Xie 1, Rong Zhang 1, Shibo Jiang 1,2,, Lu Lu 1,
PMCID: PMC7348563  PMID: 32651469

Retraction to: Cellular & Molecular Immunology 10.1038/s41423-020-0424-9, published online 7 April 2020

The authors have retracted this article1. After the publication of this article, it came to the authors attention that in order to support the conclusions of the study, the authors should have used primary T cells instead of T-cell lines. In addition, there are concerns that the flow cytometry methodology applied here was flawed. These points resulted in the conclusions being considered invalid.

[All authors agree with this retraction]

Footnotes

These authors contributed equally: Xinling Wang, Wei Xu, Gaowei Hu

Contributor Information

Shibo Jiang, Email: shibojiang@fudan.edu.cn.

Lu Lu, Email: lul@fudan.edu.cn.

References

  • 1.Wang, X., Xu, W., Hu, G. et al. SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. Cell Mol. Immunol. 10.1038/s41423-020-0424-9 (2020). [DOI] [PMC free article] [PubMed]

Articles from Cellular and Molecular Immunology are provided here courtesy of Nature Publishing Group

RESOURCES